Caris Molecular Intelligence® reports are built to maximize clinical utility in an easy-to-interpret format. We understand that clinicians need treatment information fast. That’s why the top page of every report presents all potentially relevant, actionable clinical information in an easy-to-digest summary.

Each report includes cancer drugs associated with potential clinical benefit (both on- and off-compendium NCCN Compendium®), agents associated with potential lack of clinical benefit, and relevant, open clinical trials information. The balance of the report details crucial biomarker assay results for each of the biomarkers tested, and, most importantly, you’ll discover clinical reference information that supports the association between biomarker and therapy.

Caris MI Profile Report
Click Image Above To View Larger

View an abbreviated MI Profile sample report below. Note: sample reports are provided for informational purposes only and are not intended for clinical use.